Skip to content

Clinical trials

Renal Insufficiency, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Country / region: United States Clear all

979 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20025
20035
20045
200514
200624
200725
200834
200940
201042
201148
201236
201346
201439
201544
201646
201757
201846
201953
202035
202161
202257
202347
202452
202557
202643

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed602
Recruiting121
Terminated90
Active, not recruiting47
Unknown status38
Withdrawn35
Enrolling by invitation21
Not yet recruiting20
Suspended4
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca27
VA Office of Research and Development22
University of Colorado, Denver21
Akebia Therapeutics19
Brigham and Women's Hospital19
Duke University19
Amgen18
Bayer17
University of California, San Francisco14
University of Pennsylvania14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic979
Kidney Failure, Chronic138
Kidney Diseases84
Hypertension81
Anemia77
Diabetes Mellitus, Type 269
Renal Insufficiency67
Diabetes Mellitus60
Heart Failure41
Cardiovascular Diseases40

Trials

Showing 1 to 25 of 979. Each trial links to its page on Pharma Observatory.

879 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.